Investment Pitches

Pitch Summary:
Las Vegas–based licensor of proprietary table games (e.g., 21+3, Lucky Ladies) with ~28 U.S. state licenses. Currently under an $85m all-cash takeout by Evolution AB at $3.20/share vs. $2.90 spot (~10% spread; ~30% annualized IRR if closed by YE’25). Shareholder approvals completed; only state gaming regulator approvals remain. Agreement allows shedding non-core licenses + revenue thresholds to streamline closing. EVO has a proven M&A track record (NetEnt, BTG) and no financing contingency. Downside if deal breaks looks modest: stock likely >$2.70–2.80 (vs pre-announcement $1.40–1.50) given $5.2m termination fee, $2.8m interest savings from refinancing, and ~$13m 2024 adj. EBITDA (~8.6x 2024; ~7.5x 2025). Board/insider buying post-announcement further signals confidence. With licensing approvals the only gating factor, odds of closing estimated >80%.

BSD Analysis:
This is a clean, high-probability small-cap merger arb. EVO is incentivized: the royalty payments to Galaxy alone justify most of the purchase price, and synergies in licensing, distribution, and digital adaptation are material. The spread persists mainly due to illiquidity (~$100k/day volume) and 5% regulatory ownership caps limiting arb flows. Downside is cushioned: refinancing improved FCF, termination fee provides ~$0.20/share, and valuation at ~$2.90 already reflects a healthier Galaxy (beat 2024/25 EBITDA forecasts). In my experience, when regulators are the sole hurdle and acquirer has deep experience in approvals, timing rather than deal risk drives spreads. The risk/reward is asymmetric: ~10% absolute upside (~30% annualized IRR) vs. ~3–7% downside. Key watch items: regulator updates, outside-date extensions into Jan 2026, and EVO commentary on pipeline. Overall, a compelling small-cap arbitrage with structural barriers keeping the spread wider than fundamentals suggest.

Pitch Summary:
Las Vegas–based licensor of proprietary table games (e.g., 21+3, Lucky Ladies) with ~28 U.S. state licenses. Currently under an $85m all-cash takeout by Evolution AB at $3.20/share vs. $2.90 spot (~10% spread; ~30% annualized IRR if closed by YE’25). Shareholder approvals completed; only state gaming regulator approvals remain. Agreement allows shedding non-core licenses + revenue thresholds to streamline closing. EVO has a proven M&A track record (NetEnt, BTG) and no financing contingency. Downside if deal breaks looks modest: stock likely >$2.70–2.80 (vs pre-announcement $1.40–1.50) given $5.2m termination fee, $2.8m interest savings from refinancing, and ~$13m 2024 adj. EBITDA (~8.6x 2024; ~7.5x 2025). Board/insider buying post-announcement further signals confidence. With licensing approvals the only gating factor, odds of closing estimated >80%.

BSD Analysis:
This is a clean, high-probability small-cap merger arb. EVO is incentivized: the royalty payments to Galaxy alone justify most of the purchase price, and synergies in licensing, distribution, and digital adaptation are material. The spread persists mainly due to illiquidity (~$100k/day volume) and 5% regulatory ownership caps limiting arb flows. Downside is cushioned: refinancing improved FCF, termination fee provides ~$0.20/share, and valuation at ~$2.90 already reflects a healthier Galaxy (beat 2024/25 EBITDA forecasts). In my experience, when regulators are the sole hurdle and acquirer has deep experience in approvals, timing rather than deal risk drives spreads. The risk/reward is asymmetric: ~10% absolute upside (~30% annualized IRR) vs. ~3–7% downside. Key watch items: regulator updates, outside-date extensions into Jan 2026, and EVO commentary on pipeline. Overall, a compelling small-cap arbitrage with structural barriers keeping the spread wider than fundamentals suggest.

Pitch Summary:
NZME (NZM.AX) is positioned as an activist-driven value opportunity, trading at a deep discount to underlying asset value despite dominant market positions across print, radio, and digital classifieds. The company controls ~50% of New Zealand’s newspaper market via the New Zealand Herald, ~40% of radio, and owns OneRoof, a top-tier real estate classifieds platform. Longstanding operational underperformance prompted a strategic review of OneRoof earlier this year, followed by activist investor Jim Grenon building a 13.5% stake and launching a proxy challenge. A subsequent settlement delivered Grenon a board seat and installed a new chairman aligned with change. A sum-of-the-parts analysis implies fair value of A$1.50–1.66/share versus ~A$1.04 currently, while investors earn an 8–9% dividend yield awaiting monetization.

BSD Analysis:
Legacy media is structurally challenged, but NZME’s asset mix is mischaracterized by the market, with classifieds and audio providing materially different economics than print alone. OneRoof sits in an attractive digital classifieds segment where network effects and local brand strength support valuations well above those implied in the stock. The company’s competitive position in New Zealand is unusually strong, benefiting from market concentration that limits disruptive entry. Activist involvement meaningfully alters governance risk, increasing the probability of rational capital allocation and asset monetization. The key execution risk lies in separating value realization from declining legacy cash flows without destroying optionality. Secular pressure on print remains a headwind, but it is already more than reflected in valuation. Dividend yield provides downside support while the strategic review progresses. If OneRoof is monetized at even conservative peer multiples, equity upside is substantial relative to current pricing.

Actual Post Content:
Activist involvement over at $NZM.AX looks intriguing, with potential upside of around 50%+ NZM is a major force in New Zealand’s media landscape. The company owns about 50% of the newspaper market (anchored by The New Zealand Herald), holds 40% share in the radio market, and owns OneRoof, the country’s 2nd/3rd largest real estate classifieds site. The company has been poorly managed for years, with the stock trading at a steep discount to its underlying asset value. Back in February, NZME launched a strategic review of its classifieds business, OneRoof. Shortly after, billionaire activist Jim Grenon quickly built a 13.5% stake and initiated a proxy fight to replace the board. In May, the parties reached a settlement agreement, resulting in Grenon securing a board seat, along with the appointment of a new chairman approved by him. This leadership shift, combined with the ongoing strategic review, makes it increasingly likely that we’ll see a monetisation of the OneRoof business. SOTP valuation breaks down as follows: - 6x EBITDA for the profitable, dominant publishing business - 4x EBITDA for the Audio segment (in line with comps) - 3x sales for OneRoof’s digital business - 1x sales for OneRoof's print magazine business The OneRoof valuation appears especially conservative, given where most classifieds businesses trade. Grenon’s assumptions value OneRoof at 5x sales for its digital operations and 1x for print. Overall, fair value is somewhere between A$1.50 and A$1.66/share, compared to the current share price of A$1.04. While we wait for a resolution, investors can collect an 8–9% dividend yield.

URL: https://x.com/investspecial/status/1953399660942446697

Pitch Summary:
Novo Nordisk ($NVO) is framed as an attractive long not because of short-term GLP-1 hype, but due to its century-long focus on diabetes and decades of leadership in complex protein chemistry. The pitch emphasizes Novo’s culture of transparency, ethical operating model, and unusually shareholder-aligned governance, with ~28% ownership by the Novo Nordisk Foundation reinvesting dividends into scientific research. GLP-1 drugs are seen as a continuation of Novo’s historical dominance in insulin, where innovation—not patents alone—has sustained leadership despite pricing pressure. While government pricing constraints are inevitable, they are portrayed as a feature of the business model rather than a flaw. Compared with Eli Lilly trading at much higher multiples, Novo’s 12–14× earnings valuation is viewed as compelling. The market is framed as large, durable, and non–winner-take-all.

BSD Analysis:
The metabolic disease pharma market is structurally attractive, driven by rising global obesity and diabetes prevalence, with high scientific and regulatory barriers limiting credible competition. Novo Nordisk’s competitive position is rooted in deep protein chemistry expertise, manufacturing scale, and decades-long clinician trust—advantages that are difficult to replicate even for well-capitalized peers. Secular growth in GLP-1 demand extends beyond obesity into cardiovascular and metabolic indications, supporting long-duration revenue streams. Governance structure via the foundation promotes strategic patience and R&D reinvestment, reducing risk of short-termism. Pricing pressure from payors is inevitable, but history shows innovation cycles—not price hikes—drive economic returns in this category. Valuation at a mid-teens earnings multiple appears to discount patent cliffs while underappreciating Novo’s demonstrated ability to refresh its portfolio. Key risks include competitive innovation velocity and reimbursement tightening, not demand durability. On normalized earnings power, Novo offers asymmetric value relative to higher-multiple peers in a structurally expanding market.

Actual Post Content:
$NVO is probably a no-brainer investment. And it’s not why everyone thinks. 1. 100 year old company only focused on diabetes and GLP-1 for 25 years. the most transparent ethical pharma co ever 2. ⁠GLP is Protein chemistry which is notoriously complex and r&d needs are high This is trading at 12-14 times earnings. I can’t predict the next wonder drug. Neither can I tell anything from phase-3 trail results. But I can tell this - NOVO is transparent to a fault. No window dressing in their annual reports. They have a website only to display all their trail results for everyone to access. There is zero obligation for this company to maintain such a site. It has documentation of their trial design and results. $NVO Novo Nordisk way is a set of principles basis which they operate where one of the founding principles is to make money for shareholders which will eventually help them to stay in business so they can do good for their patients. 28% of Novo nordisk is owned by a foundation which oversees stability of the company. The dividends is reinvested into other startups to promote scientific research. The incentives are aligned to stay durable. Protein chemistry isn’t easy. If I am worried about GLP patent expiring, I should also be worried about insulin patents. Insulin was discovered in 1922. If Novo can dominate insulin market with innovation, perhaps they can do same with GLP-1. There is inherent price pressure with insulin and probably with GLP-1. This comes in the form of Medicare issues, govt issues. It’s not a bug but a feature. Pricing power lies only in new drugs. It was the case with insulin too. That’s the business if you want to buy into it. It doesn’t matter who maintains the lead between $LLY vs $NVO. Both are fantastic companies and likely to do well. Obesity and Diabetes are huge problems. This is not a winner take all market. Except $LLY trades at 60 times earnings That’s the investment case. Maybe this will become a Visa-Mastercard type duopoly. Maybe. But I am getting ahead of myself. Right now, the returns from $NVO looks good given its price.

URL: https://x.com/earningsb4hugs/status/1953435434211541006

Pitch Summary:
On the one hand, people pay managers to diversify across large cap, small cap, international, emerging markets, bonds, and alternatives. They pay a fee on all that and get maybe a 1% or 2% dividend yield. On the other hand, you can be paid to get all of that in Alliance Bernstein, which is used in some income-oriented portfolios. As a unit holder, rather than being a client, you’re a partial owner of this respected publicly traded asset manager. Meaning that instead of being a fee payer, you’re a fee collector.
As an LP, the company pays out its earnings, and the recent distribution, which varies with operating profits, yields about 8%. Unlike most active managers, the company has been a recipient of net asset inflows for several years. Between such ordinary external growth, if it continues, and long-term appreciation of the portfolio, achieving an extra 2% is a modest hurdle. The company is also majority owned by Equitable Holdings, which in April increased its interest from 51% to 69% and also invests in Alliance Bernstein funds.
So, own the manager, take some of the fees, start off 80% of the way toward a 10% return. It’s a different return model than buying a portfolio of ETF asset classes, or than a “dividend aristocrats” ETF that might have a 3%-ish yield.

BSD Analysis:
AllianceBernstein is a high-quality, asset-light investment manager whose stock is poised for a major re-rating driven by a massive, high-impact real estate catalyst and a powerful fee-based model. The core thesis is the accelerating momentum of its $50 billion Wealth Management business and its strategic shift to its new Nashville headquarters. The move to the lower-cost Nashville hub is expected to deliver substantial, structural margin expansion and drive operational efficiency. Crucially, the company's low P/E multiple and high dividend yield (∼7%) fundamentally misprice the stability of its $725+ billion Assets Under Management (AUM) and the predictable, high-margin fee income. This is a defensive compounder in the financial sector, offering a high, visible yield combined with a major, multi-year catalyst from its strategic real estate transition.

Pitch Summary:
Japan Elevator Service Holdings (JES) is the largest independent elevator and escalator maintenance and repair service provider in Japan, with a 10% market share. Typical clients are building owners and real estate maintenance and management companies legally required to have annual inspections on their elevators and escalators. They generally enter contracts that include an annual inspection, monthly checkup, and repairs when necessary. This arrangement provides a recurring and stable revenue stream. There are over 900,000 elevators and escalators under such contracts in Japan, and the number has expanded about 3% annually during the past decade.
When Chairman, CEO, and President Katsushi Ishida founded JES in 1994, the elevator and escalator service market was over 95% dominated by five manufacturers: Toshiba, Mitsubishi, Hitachi, Fujitec, and Japan Otis. The remaining 5% was shared by hundreds of independent service providers; manufacturers competed for new elevator and escalator sales and installation.
However, in this business, once one receives installation orders, the maintenance service contracts naturally accrue the manufacturer, as it already has full understanding of the models; most importantly, it can easily set aside adequate replacement parts. Moreover, manufacturers have no incentive to take maintenance contracts for competitors’ models, just like Toyota dealers will not actively seek maintenance work for Ford automobiles. As a result, the service price is set high enough to recoup the low profit, if any, resulting from the price competition around installment.
Maintenance and repair services, even for a standard model, require thousands of parts. Covering available models of major brands with guaranteed timely service means having an inventory of more than 150,000 parts. The control panel is the most crucial, in that genuine manufacturers’ control panels have unparalleled performance and durability compared to generic versions. The inability to secure these often hinders independent service providers from providing high-quality services on par with manufacturers, and is a hurdle in expanding service networks.
Another obstacle is the ability to hire qualified inspectors. In Japan, only inspectors with a national qualification—which requires certain electrical and electronic engineering degrees and years of on-the-job experience—can conduct annual inspections. Independent operators need an appropriate number of such inspectors to sufficiently cover their customer base.
An Owner-Operator’s Entrepreneurial Counter-Perspective
At this point in the description of this industry, one might justifiably conclude that this slow-growth sector offers hardly any business opportunity for independent operators, other than competing in a zero-sum game to take small market share
However, in the early 1990s, Chairman Ishida—a licensed elevator inspector himself—saw a business opportunity in an industry whose high barriers to entry could actually become a competitive benefit upon overcoming them and achieving sufficient scale. Having worked for a building maintenance company, and for an independent elevator maintenance service provider, Chairman Ishida was convinced a well-run business could generate double-digit operating margins, even at half the price of the leading manufacturers. To seize market share, he was determined to build a company that would provide services at their level or better.
So, in 1994, at age 28, Chairman Ishida founded the company alone—with no funds, no partners, and no employees. Nevertheless, he was determined to provide the highest-quality professional service from day one. When visiting potential customers as a salesperson, he would change into a business suit, then switch back to workwear to do maintenance and inspections. He reviewed inspection reports directly with customers before and after; this was not common among typical industry engineers, who would focus on the inspection work itself and delegate customer communication to a sales department. He often slept at the office to respond to emergency calls.
As the number of contracts grew, he needed to hire and train more employees, and he needed to procure enough parts for timely service. For the first three years, JES was literally a hand-to-mouth operation, and Chairman Ishida had to fund the running cost with short-term loans just to meet immediate cash needs. Within ten years, though, the number of maintenance units reached 5,000. At this point, he managed to hire a full management team to run the business.
In 2007, JES hit a milestone as an independent service provider: matching the service capabilities of the leading manufacturers upon developing a 24-hour remote monitoring and controlling service. This technology enabled the company to monitor elevator and escalator operating status 24 hours a day, seven days a week—and to detect small irregularities, which enabled targeted preventive repair and parts replacement to reduce the incidence of malfunctions and breakdowns. Until that moment, this type of service had only been provided by the leading manufacturers, as it required access to the control panel, and required resolving their unique data transmission and protocols. Toward this goal, Chairman Ishida had hired system engineers to research and develop a remote monitoring system compatible with various models of elevators and escalators, and even obtained a patent on the technology.
That same year, JES established an original engineer-training program and internal qualification system called “Step 24.” Even before this program, Chairman Ishida undertook a training program that systematized the skills and experience of top engineers, and collected and researched maintenance information and data for various models. Through what became a 24-lecture series and on-the-job training, new employees could acquire the skills and knowledge needed to attain a national inspection license in one year. Moreover, the program trained engineers to individually conduct full maintenance work for several models, enabling the company to provide equivalent quality services to the leading manufacturers.
Critically, and unlike these competitors providing maintenance only to their brands, this meant JES was now able to leverage its operation as its engineers expanded their capabilities and productivities to include more elevators in a given coverage area. Being an engineer himself, Chairman Ishida respected engineers and always knew they were the cornerstone of the operation (later, in 2019, he set up a “Engineer Meister Program” with five accreditation levels to incentivize engineers with the best skill sets to maintain the service quality).
At the same time, Chairman Ishida sought to publicly list JES to increase its credibility and transparency in furtherance of expansion. It took just over a decade to prepare for the listing; the focus was on human resource development, enhancing technology and capability, and securing genuine parts. JES went public in 2017.
The same year, JES completed construction of an R&D test tower and innovation center with ten elevators to examine control systems and motors. It conducted thousands of tests—allowing further improvement on maintenance and repair offerings and operational efficiency—and developed new services for the market.
In 2018, the company developed its next-generation control system, Quick Renewal, which was compatible with the general models of all the equipment manufacturers. Typically, elevators’ stated useful life is 20 to 25 years; in practice they operate 25 to 30 years. At that point, they need a full renewal, which entails replacing the control system, motors and all electric systems—and requires about one full week of downtime. Quick Renewal necessitates just a half-day of down time, and at half the price.
Illustratively, a building operating for 60 years usually requires three full equipment renewals. With Quick Renewal, three controller system replacements are needed, but only two motor replacements, leading to a significant reduction of customers’ downtime and maintenance cost. For JES, Quick Renewal was an important offering to induce customers to switch maintenance companies and add to its service contracts portfolio.
The growth in the number of maintenance units accelerated following the company’s IPO and introduction of new services. JES’s market share reached 10% in 2023; in 2024 it added over 13,000 units, taking another 1.3% of market share.
It is important to recognize this “the only one” position Chairman Ishida has built since founding JES. Its maintenance units’ failure rate is as low as 1%, equivalent to that of leading elevator and escalator manufacturers, and one-fifth that of the independent service providers.
The JES offering price remains about 30% to 40% below that of the leading manufacturers. For independent service providers, it is not easy to set a competitive price without operational scale, since they need to hire licensed engineers and procure parts, essentially where JES was in its early years.
As a result, the company is taking market share both from the manufacturers and the smaller independent providers. In the recent inflationary environment, those competitors have been raising their prices, while JES continues to focus on advancing its market share, thereby accumulating more maintenance contracts.
The company is also expanding its coverage area, entering second- and third-tier cities and acquiring smaller independent service providers, which usually start from a loss-making position until the branch achieves sufficient scale.
Even with the advancements to date, having improved the operating margin from 12.7% to 17.7% during the last five years, management appears confident about reaching 20% in the coming two years. In the longer term, once the growth investment spending decelerates, management sees a 30% margin as a natural, sustainable profitability level.
Most recently, inquiries from real estate management companies are rising as they try to lower elevator and escalator maintenance costs as part of broader building maintenance cost reductions. JES also established strategic tie-ups with banks that are financing new real estate development or re-development as another avenue to secure new maintenance contracts.
There is an opportunity for even more expansion domestically. In other developed markets outside Japan where major maintenance providers compete, independent service providers typically represent a 50% market share. That should be possible in Japan, too. For the near term, JES is aiming to take at least a 30% market share, approximately three times its current level.

BSD Analysis:
Japan Elevator Service Holdings is a high-growth, niche monopoly in the critical, non-cyclical market of elevator maintenance and repair, offering a defensive compounder with a clear path to scale. The core moat is its focus on third-party, non-OEM maintenance, which is structurally cheaper and provides a vital, high-margin, recurring revenue stream. The company is executing a clear strategy of aggressive regional expansion across Japan, targeting the vast base of elevators installed by its larger competitors. Crucially, its revenue is entirely non-discretionary, guaranteed by the mandatory safety regulations that require regular maintenance, ensuring stability regardless of the economic cycle. The stock is trading at a premium justified by its consistent double-digit revenue growth and the clear, massive market opportunity of converting existing maintenance contracts to its superior service model.

Pitch Summary:
JOE owns approximately 167,000 acres in the Florida Panhandle. It has been widely known that JOE traded for a tiny fraction of its liquidation value for years, but without a catalyst, it was always perceived to be "dead money." Over the past few years, the population of the Panhandle has hit a critical mass where the Panhandle now has a center of gravity that is attracting people who want to live in one of the prettiest places in the country, with zero state income taxes and few of the problems of large cities. The oddity of the current disdain for so-called "value investments" is that many of them are growing quite fast. I believe that JOE may grow revenue at a rapid rate for the foreseeable future, with earnings growing at a much faster clip. Meanwhile, I believe the shares trade at an attractive multiple on Adjusted Funds from Operations (AFFO), while substantial asset value is tossed in for free. Besides the valuation, growth, and high Return on Invested Capital (ROIC) of the business, why else do I like JOE? For starters, land tends to appreciate rapidly during periods of high inflation. More importantly, I believe we are witnessing a massive population migration as people with means choose to flee big cities for somewhere peaceful. I suspect that every convulsion of urban chaos and/or tax-the-rich scheming will launch JOE shares higher, and it will ultimately be seen as the way to "play" the stream of very wealthy refugees fleeing for somewhere better.

BSD Analysis:
The St. Joe Company is a unique, high-quality real estate developer that functions as a leveraged bet on the long-term, compounding value of its massive land holdings in the Florida Panhandle. The core moat is its ownership of 170,000 acres in one of the fastest-growing regions of the US, providing a multi-decade runway for monetizing land and commercial development. The company's strategy is to create fully integrated Master Planned Communities (MPCs), which drive sticky, recurring revenue from long-term commercial leases and a high-margin hospitality segment. St. Joe is a conviction bet on the intrinsic value of land, offering a pure, long-duration growth story in a market with favorable demographic tailwinds.

Pitch Summary:
Vail endured a difficult ski season compounded by a poorly managed PR crisis related to the Park City Ski Patrol strike. The managers did not originally purchase the stock expecting a turnaround, but that’s what it became. Their exit reflected opportunity cost and a desire to step back while the company sorts through reputational and operational issues. With Rob Katz returning as CEO—the architect of the multi-mountain pass—they are monitoring but not yet convinced.

BSD Analysis:
Vail Resorts is an oligopolist in the destination mountain resort market whose financial dominance is structurally secured by its Epic Pass subscription model. The core moat is its massive scale (41 resorts across four continents) and the pre-season revenue predictability granted by the non-refundable, fixed-price pass. The entire thesis is a high-quality annuity: the Epic Pass locks in customer loyalty, eliminates the seasonality risk of single-day tickets, and provides superior operating leverage. While the stock faces short-term volatility from unpredictable weather patterns, its long-term financial stability and superior pricing power in a high-demand, experiential leisure market make it a compelling compounder.

Pitch Summary:
The quarter opened with news that Arm had approached Alphawave about a takeover, followed by Qualcomm formalizing their own interest. After deadline extensions, Qualcomm agreed to acquire Alphawave for $2.4B (≈183p/share). The outcome was favorable, but the journey was volatile: multiple >20% down days, one nearly 50% intraday collapse, and even a three-week trading suspension in 2023 due to audit delays. The position offered poor return per unit of stress, and the managers concluded Broadcom could have offered similar macro exposure with less risk.

BSD Analysis:
Alphawave Semi is a high-growth, vertically integrated semiconductor pure-play whose technology is essential for the AI and data center buildout. The core moat is its high-speed connectivity IP and custom silicon solutions, which accelerate data to travel faster, more reliably, and at lower power—a critical necessity in the era of exponential data growth. The entire thesis is a direct play on Compute + Connectivity, with its 1-224G SerDes, PCI-Express 6.0, and HBM3 interfaces being non-discretionary for next-generation HPC and AI applications. As a long-standing partner of TSMC on leading-edge 3nm and 4nm process nodes, Alphawave is an indispensable enabler of the multi-year AI infrastructure supercycle.

Pitch Summary:
Although fundamentals looked attractive—we would otherwise be buyers—the exit was driven by a thesis-violation around security. A sophisticated AI voice-mimicry hack compromised personal accounts despite 2FA, undermining the belief that PayPal’s core moat was superior security. The original thesis assumed PayPal’s systems, built by Max Levchin and improved for decades, represented best-in-class online transaction safety. Instead, firsthand experience suggested systemic weaknesses. Given security was central to our qualitative thesis, conviction broke and we exited.

BSD Analysis:
PayPal is a deeply discounted fintech titan executing a crucial, high-stakes pivot to reclaim its position as an innovation leader. The core thesis is a leveraged bet on the successful transition of its platform from a checkout button to an integrated digital wallet and financial ecosystem. The company is aggressively moving to monetize its massive installed base (over 428 million active accounts) with new services, focusing on driving higher transactions per account (TPA). The stock is trading at a trough valuation, penalized by a slowdown in user growth and competition. However, its $7.7 billion in Free Cash Flow and a new CEO focused on surgical cost cuts and innovation create a compelling value-with-a-catalyst scenario.

Pitch Summary:
Fever-Tree announced a 50/50 partnership with Molson Coors for its US business, including profit guarantees from 2026–2030. Molson invested at an £835m valuation and acquired US assets for cash, funding a share repurchase program. Molson will take over supply chain, logistics, and distribution—solving Fever-Tree’s greatest historical constraints. The US business has grown 2.7x since before the pandemic but generated little profit due to inefficiencies; synergies with Molson should sharply lift margins. Management guides to a turbulent transition year, but once complete, group-wide operating margins could rise into the 20%s or even 30%. With a mid-teens EBIT multiple that halves if margins double, valuation is extraordinarily cheap for an industry-leading premium brand. A step-change in US sales is plausible given historical success of large-beverage partnerships.

BSD Analysis:
Fevertree is a high-quality, high-growth premium mixer pure-play whose stock is an accelerating international growth story. The core moat is its innovation-led brand, which commands a premium price point and is the undisputed "Best Selling" and "Top Trending" mixer brand globally. The entire thesis is a leverage bet on geographical diversification, with the company aggressively investing in new growth markets like the US and Australia to capture the long-term trend of premium spirits and easy-to-make cocktails. This strategy is generating strong cash flow which management is using to drive consumer recruitment and capture first-mover advantage in emerging markets.

Pitch Summary:
Roku has been a wild ride, but through volatility the core business has strengthened. Bears expected Amazon and Google to crush Roku, yet Roku increased device and household share to over half of US households. ARPU stalled due to a misguided attempt to build a walled-garden DSP strategy while M&E ad spend collapsed. These issues have now largely resolved. Roku has opened up to programmatic demand from The Trade Desk, FreeWheel, and Amazon, enabling far richer monetization and better economics for advertisers—a win/win. The Roku Channel continues expanding, with improved content recommendation engines boosting engagement. With M&E as a smaller and stable revenue slice, platform revenue is reaccelerating toward high-teens growth. Amid tariff fears, markets overlooked Roku’s installed-base moat: slower TV sales raise barriers for competitors. At purchase, 25% of market cap was net cash and shares traded at a high-teens 2026 EBITDA multiple with an explicit commitment to GAAP profitability in 2026.

BSD Analysis:
Roku is the undisputed, high-margin software platform king of Connected TV (CTV) whose stickiness and scale are severely undervalued. The core thesis is driven by its dominant operating system (OS) market share in North America, acting as the indispensable gatekeeper between viewers, content, and advertisers. The company's Platform Revenue (subscriptions and advertising), which boasts 58% Gross Margins, is the true compounding engine. While the stock is penalized by cyclical advertising spend and volatile hardware sales, its 79.8 million active accounts and the relentless, non-cyclical shift of ad dollars from linear to CTV ensure its long-term growth is secured.

Pitch Summary:
Workday offers mission-critical HR software for Fortune 500 companies and is steadily expanding into finance workflows. Revenue continues compounding double digits through both new logo wins and land-and-expand momentum. Historically, valuation and margin concerns kept us cautious, but new CEO Carl Eschenbach is driving meaningful operational streamlining. Early 2025 restructuring and ongoing margin progress demonstrate commitment to converting revenue growth into earnings growth. SaaS multiples have compressed materially in the AI era, creating attractive entry valuations. At purchase, shares traded at 25x current-year EPS, 18x EBITDA, and 17x FCF—all growing nearly 20%. Returns should track FCF growth with potential multiple expansion as Workday proves resilient to AI disruption. Upside is higher if growth reaccelerates, which we view as more likely than not.

BSD Analysis:
Workday is a high-quality, high-growth enterprise cloud applications leader whose stock is a conviction bet on the non-discretionary corporate shift to modern, unified HR and financial software. The core moat is its single, unified software platform for Financial Management and Human Capital Management (HCM), which creates exceptionally high switching costs for large enterprises. The entire thesis is driven by its successful integration of Generative AI across the platform, using its massive, proprietary data set to embed AI into planning, financial reporting, and HR decisions. This AI advantage is driving superior subscription revenue growth and margin expansion. Workday is an indispensable software provider, leveraging the non-cyclical corporate need for efficiency and automation to deliver double-digit growth.

Pitch Summary:
Although everyone thinks of Peloton as a pandemic darling whose fancy bikes turned into clothing racks, at its core PTON has become a cash-generative $1.6 billion recurring-revenue business. Churn is higher today than during the pandemic, though still at enviable levels. Most importantly, the balance sheet is finally cleaned up, allowing new CEO Peter Stern to focus on re-igniting growth rather than putting out fires. Peloton’s unique brand equity, high NPS, cult-like instructors and deep user trust remain major competitive advantages. Strength training represents a massive opportunity, with 2M+ unique members already engaged. Lululemon and Google have effectively ceded the category to Peloton. The company’s new AI-driven personalized training plans strengthen platform stickiness and widen the value gap between Peloton’s offering and its pricing. Structural fixed-cost reductions and right-sized inventory have returned customer acquisition to attractive LTV:CAC ratios. Pricing power exists but management intends to “earn the right” through continued enhancements. These levers collectively make pricing, margin recovery, and growth more likely over the next three years. Peloton expects $330–350M of EBITDA and $250M of FCF this year, with a substantial improvement next year as interest costs fall and savings cascade.

BSD Analysis:
Peloton is a high-beta, high-risk turnaround bet whose stock is currently priced for bankruptcy, creating an asymmetric risk/reward opportunity. The core thesis is a strategic pivot from a capital-intensive hardware model to a high-margin, recurring software and content annuity. The new CEO is executing a ruthless overhaul, slashing fixed costs, eliminating excess inventory, and refocusing marketing efforts. The company's true moat is its ubiquitous brand and its sticky subscriber base (∼7 million total members). The market is missing the value of its massive recurring revenue stream, with subscriptions driving 44% of total revenue. Success hinges on whether the new management can stabilize the hardware business and transition to sustainable Free Cash Flow generation.

Pitch Summary:
After commercial approval of Casgevy, CRSP shares traded over $90. At their worst in the April crash, shares changed hands at $30, a 2/3rd discount to their post-approval peak. The trade war would ultimately have a negligible impact on CRSP, but shares dropped nearly 30% in the Spring collapse. This made little sense to us, especially given the substantial cash balance the company has built with prudent financings along the way. When we bought shares of CRSP, the company’s Enterprise Value was below $800m, boasting over $1.8 billion in net cash. As the name would suggest, CRSP is a first-mover and leader in the Cell and Gene Therapy (CGT) space and the first to bring a life-changing gene editing therapy to FDA approval and commercial availability. We know the company well from following a basket of cell and gene therapy companies. CRSP’s management has excelled at balancing capital discipline with R&D ambition. Now, with a commercial product and arguably the strongest balance sheet in its space, CRSP is in an enviable position, affording the opportunity to lean into its pipeline, while competitors retrench to conserve cash. We believe the company will retain over $900 million in cash by the time it turns cash flow positive. In essence, we’re buying Casgevy at a steep discount and getting the pipeline and cash for free. This is one of the more asymmetric setups we’ve encountered.

BSD Analysis:
CRISPR Therapeutics is the undisputed, high-stakes leader in the gene-editing revolution, commanding a premium valuation justified by its first-mover status and a deep, multi-program pipeline. The core thesis is a conviction bet on the successful commercialization of Casgevy, its flagship gene-editing therapy for sickle cell anemia and beta-thalassemia, which has successfully completed Phase 3 trials. The company's moat is its foundational CRISPR technology—the molecular scissors used for precise DNA modification—which has applications across genetic disorders, oncology, and even agriculture. While the stock is volatile due to its reliance on clinical and regulatory milestones, its advanced pipeline and diversification across in vivo and ex vivo editing position it as the essential, long-term leader in the next generation of medicine.

Pitch Summary:
Take Mitsubishi Estate, for example. The company owns prime real estate in the Marunouchi business district adjacent to the Imperial Palace in Tokyo. At its late-1980s peak, this land was said to be worth more than all of California. Yet today you can buy this world-class commercial property portfolio—basically the Midtown Manhattan of Japan—for roughly half its appraised value. Factor in a yen that has weakened by nearly 50% from its highs, and dollar-based investors are purchasing at an even greater discount. Beyond valuation, there are additional structural tailwinds in Japan. Inflation has finally returned, and with it, rent inflation, which flows directly through to the bottom line in labour-light businesses like real estate. Corporate governance continues to improve, with many companies—not just Mitsubishi Estate—increasingly willing to buy back stock trading at steep discounts to book value. The combination of a cheap currency, discounted assets, governance reform, and rising domestic inflation creates a compelling setup for revaluation.

BSD Analysis:
Mitsubishi Estate is a deep-moat, long-duration real estate giant whose core value lies in its unassailable ownership and development of premium assets in Tokyo’s Marunouchi district. The core thesis is a structural pivot to a more diversified, high-growth model focusing on three segments: domestic asset business, international asset business, and non-asset business. The company is aggressively investing in its future through a Long-Term Management Plan 2030, fostering a corporate culture that encourages business model innovation and taking on challenges. This approach includes recruiting specialists and investing in training programs to deepen essential expertise. Mitsubishi Estate is a defensive compounder whose immense balance sheet strength and long-term perspective (its "forward-looking DNA") provide a superior platform for creating new value.

Pitch Summary:
One of them, Offshore Energy Services provider Tidewater, was a long-tenured, lucrative investment for the Fund that we had sold in the First Half of 2024, as detailed in our June 2024 Semi-Annual Letter. As we explained last year, we continued to like Tidewater’s prospects and admire what management had achieved over the preceding several years, but with Tidewater’s share price rising from a low of less than $5 in 2020 during the early days of the pandemic to the mid-$90s and over $100 in June 2024, we decided to eliminate the position from the Fund… Since then, due to similar factors that weighed on Valaris… as well as general concerns about tariff implications… Tidewater’s stock price fell to the low-$30s at the height of the tariff turmoil in April, and it is currently trading in the low-$50s. With our sale from the Fund in 2024 having been valuation-driven, and with nothing else changing about our investment thesis other than the valuation, we once again acquired shares of Tidewater in the First Half of 2025 at what we believe to be a significantly discounted valuation.

BSD Analysis:
Tidewater is the unassailable, high-leverage pure-play on the multi-year supercycle in deepwater offshore energy, converting a decade of underinvestment into massive shareholder returns. The core thesis is a structurally constrained vessel supply—with 40% of OSVs aging beyond their economic life by 2035 and virtually no new shipbuilding capacity until 2026—giving Tidewater total pricing power. This dominance has fueled relentless profitability, with revenue growing 33.3% and the average day rate surging 26.6% in 2024 alone. Management is surgically using the resulting $331 million in Free Cash Flow to execute an aggressive $500 million share repurchase program, signaling confidence that the stock is undervalued by over 50% based on intrinsic value estimates. The stock is a conviction bet on non-cyclical offshore production support (50% of revenue) and accelerating demand from subsea construction and offshore wind, which will drive utilization and day rates higher for years to come.

Pitch Summary:
Valaris is a leading provider of offshore contract drilling services and owns one of the largest fleets in the industry. Industry consolidation since 2019 has restored supply discipline, while rig supply continues to shrink as older units are scrapped. Demand for offshore production is rising due to its lower cost relative to shale. Valaris emerged from bankruptcy with a healthier balance sheet and improving utilization and day rates. The company trades at a discount to replacement and secondary market value of its fleet and has executed meaningful share buybacks, offering substantial upside if conditions continue to tighten.

BSD Analysis:
Valaris is a leveraged bet on offshore drilling’s revival, operating one of the world’s largest jack-up and floater fleets. After restructuring, the balance sheet is cleaner and day-rates are finally rising as offshore capex rebounds. Supermajors are committing to long-cycle deepwater projects again, which directly benefits Valaris. The company still carries high operational and contract-cycle volatility, typical for drillers. Utilization improvements and multi-year contracts can meaningfully rerate earnings. But this is a high-beta commodity services business — feast-or-famine by nature. Pure torque for investors bullish on offshore oil activity.

Pitch Summary:
London-listed Travis Perkins PLC (“Travis Perkins”) is the largest distributor of building products in the United Kingdom. Through its network of 725 branches across the U.K., Travis Perkins distributes building materials (lumber, bricks, cement, roofing supplies, etc.) to a wide array of wholesale and retail customers, including nation-wide homebuilders and local renovation and construction contractors. Additionally, the company operates one of the largest retail businesses in the U.K., which sells tools, hardware and supplies through its 740-plus store Toolstation franchise. Both businesses have had a very challenging past several years as the U.K. renovation and construction market has seen a significant slowdown principally resulting from rising interest rates. This was further exacerbated by strong price inflation in many building products following the COVID-19 pandemic, additionally slowing demand and weighing on fundamentals. Aside from the macroeconomic challenges, the business has been negatively impacted by a range of company-specific issues, including the historic misallocation of resources, a subpar approach to staffing that negatively impacted revenues, and the failed buildout of the Toolstation France business (a business they completely exited last year). In conjunction with this, Travis Perkins has undergone a years-long restructuring process, including selling two divisions and adding a new Chairman, CFO, and a new CEO (joining this year). This combination of sustained weak macro fundamentals and the many self-inflicted issues predictably resulted in the stock declining considerably (by almost 66%). However, we believe that most of these weak fundamentals are transitory and have largely obscured the significant underlying core value of the business. As the leading distributor with a market share of ~2x the nearest competitor, we believe Travis Perkins is well-positioned for an eventual easing of interest rates, or alternatively, a thawing of the renovation and construction markets as higher interest rates become normalized. Additionally, the business has been working to fix many of its self-inflicted issues. The corporate-level improvements, combined with a stabilized or improving macro picture, should drive meaningful profitability improvement that is not currently recognized in the valuation, in our view. We believe this is especially true when we consider the fact that the U.K. has a substantial housing shortage and very aged housing stock, implying an elevated need for renovation and retrofitting for current technologies, environmental improvements, and building standards. We believe Travis Perkins also has many levers to drive value creation independent of the market, including a large property portfolio that analysts estimate could be worth £1 billion, significant profitability improvements from closing Toolstation France, and increased working capital efficiency. In summary, we believe that, given the macroeconomic weakness and the significant self-inflicted company-specific issues, we were able to acquire shares in the leading business in its industry at a discounted price relative to the current “what is” profitability, which provides upside potential.

BSD Analysis:
Travis Perkins is the backbone of the UK’s building-materials distribution supply chain, serving contractors, tradespeople, and construction firms. The business is deeply cyclical, and the current UK housing environment hasn’t been kind. But Travis’ scale, branch network, and trade relationships give it strong competitive position when construction activity recovers. Margin pressure persists, though cost actions and portfolio simplification are helping. The long-term demand drivers — renovation, infrastructure, and housing shortages — remain intact. This is a recovery play tied to UK macro and construction volumes. When the cycle turns, Travis Perkins’ operating leverage shows up fast.

Pitch Summary:
Banco Bradesco (“BBD”) is one of Brazil’s largest banks, possessing a large banking footprint across the country and operations that include retail and commercial lending, in addition to various other financial services, including leading insurance businesses and capital markets activities. In observing the Brazilian banking industry over the years, we have admired a number of its attractive attributes, including a fairly concentrated industry structure that generally lends itself to relatively higher profit margins. In addition, Brazil’s long history of macroeconomic volatility has, in our view, effectively “battle-tested” some of the country’s major banks, which are generally well capitalized and reasonably managed as a consequence of having been compelled to navigate sometimes quite challenging circumstances. Yet, despite those attractions, valuations that were not cheap enough for us kept us from investing in the space. That began to change in 2024 as investor sentiment towards Brazil soured significantly. This stemmed, in part, from concerns regarding political intervention and increased government spending under President Luiz Inácio Lula da Silva's administration, and the potential implications for the Brazilian economy and fiscal situation. Brazil’s Bovespa Index was one of the worst performers in 2024, declining by nearly 30% in USD terms for the year, while the local currency, the Brazilian Real (BRL), depreciated by over 20% against the USD in 2024. Faced with a significant decline in its currency and resultant and/or coinciding inflationary pressures in the economy, the Central Bank began raising interest rates in late 2024, with its target rate increasing from 10.5% to 15% at present – weighing on both consumers and businesses (i.e., BBD’s customers) alike – while market expectations at the time of future rate hikes to come in 2025 resulted in generally gloomy investor sentiment towards many Brazilian businesses, including Banco Bradesco. Against this backdrop, Banco Bradesco shares sold off sharply, to the point where they traded at what we believe is an unusually depressed valuation, both relative to their own history as well as in relation to the company’s underlying earnings power.

BSD Analysis:
Bradesco is one of Brazil’s largest private banks, providing broad exposure to retail banking, insurance, and payments in a growing but volatile economy. Credit quality and provisioning cycles dominate near-term results, and Bradesco has been on the wrong side of them recently. Still, its distribution scale, deposit base, and insurance arm give it a strong structural foundation. As Brazil’s rate cycle normalizes, NII and profitability should improve. Competition from digital challengers like Nubank raises pressure, but the market is big enough for multiple winners. Bradesco isn’t the cleanest Brazilian bank, but it’s still a leveraged play on Brazilian credit stabilization. Cyclical, with a payout profile that improves as the macro calms.